Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Beyer

Showing results (121-130 of 225) with videos related to

Pageof 23
Sort By:
Critical Care (London, England)|February 21, 2023
Response to the Letter by Spurling and ColleaguesCraig I Coleman, Olivia S Costa, Stuart J Connolly, et al.
Circulation|April 15, 2024
The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 SubanalysisDeborah M Siegal, Nauzer Forbes, John Eikelboom, et al.
Thrombosis Journal|March 10, 2015
Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairmentRupert M Bauersachs, Anthonie Wa Lensing, Martin H Prins, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 25, 2023
Periinterventional Management of Edoxaban in Major Procedures: Results from the DRESDEN NOAC REGISTRYChristina Köhler, Luise Tittl, Ulrike Hänsel, et al.
Anesthesiology|October 3, 2023
Monitoring of Argatroban in Critically Ill Patients: A Prospective Study Comparing Activated Partial Thromboplastin Time, Point-of-Care Viscoelastic Testing with Ecarin Clotting Time and Diluted Thrombin Time to Mass SpectrometryLars Heubner, Reinhard Oertel, Oliver Tiebel, et al.
The Lancet. Haematology|November 26, 2020
Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort studyJan Beyer-Westendorf, Luise Tittl, Ingrid Bistervels, et al.
Research and Practice in Thrombosis and Haemostasis|December 8, 2021
Cancer-Associated ThrOmboSIs - Patient-Reported OutcoMes With RivarOxaban (COSIMO) - Baseline characteristics and clinical outcomesAnthony Maraveyas, Jan Beyer-Westendorf, Agnes Y Lee, et al.
Research and Practice in Thrombosis and Haemostasis|November 3, 2022
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registryStephanie Müller, Luise Tittl, Victoria Speed, et al.
Scientific Reports|May 6, 2021
Homoarginine and methylarginines independently predict long-term outcome in patients presenting with suspicion of venous thromboembolismRoman N Rodionov, Jan Beyer-Westendorf, Stefanie M Bode-Böger, et al.
Journal of Thrombosis and Thrombolysis|May 24, 2015
Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocolJessica Kepplinger, Alexandra Prakapenia, Kristian Barlinn, et al.
Pageof 23

Showing results (121-130 of 225) with videos related to

Sort By:
Pageof 23
Critical Care (London, England)|February 21, 2023
Response to the Letter by Spurling and ColleaguesCraig I Coleman, Olivia S Costa, Stuart J Connolly, et al.
Circulation|April 15, 2024
The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 SubanalysisDeborah M Siegal, Nauzer Forbes, John Eikelboom, et al.
Thrombosis Journal|March 10, 2015
Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairmentRupert M Bauersachs, Anthonie Wa Lensing, Martin H Prins, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 25, 2023
Periinterventional Management of Edoxaban in Major Procedures: Results from the DRESDEN NOAC REGISTRYChristina Köhler, Luise Tittl, Ulrike Hänsel, et al.
Anesthesiology|October 3, 2023
Monitoring of Argatroban in Critically Ill Patients: A Prospective Study Comparing Activated Partial Thromboplastin Time, Point-of-Care Viscoelastic Testing with Ecarin Clotting Time and Diluted Thrombin Time to Mass SpectrometryLars Heubner, Reinhard Oertel, Oliver Tiebel, et al.
The Lancet. Haematology|November 26, 2020
Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort studyJan Beyer-Westendorf, Luise Tittl, Ingrid Bistervels, et al.
Research and Practice in Thrombosis and Haemostasis|December 8, 2021
Cancer-Associated ThrOmboSIs - Patient-Reported OutcoMes With RivarOxaban (COSIMO) - Baseline characteristics and clinical outcomesAnthony Maraveyas, Jan Beyer-Westendorf, Agnes Y Lee, et al.
Research and Practice in Thrombosis and Haemostasis|November 3, 2022
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registryStephanie Müller, Luise Tittl, Victoria Speed, et al.
Scientific Reports|May 6, 2021
Homoarginine and methylarginines independently predict long-term outcome in patients presenting with suspicion of venous thromboembolismRoman N Rodionov, Jan Beyer-Westendorf, Stefanie M Bode-Böger, et al.
Journal of Thrombosis and Thrombolysis|May 24, 2015
Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocolJessica Kepplinger, Alexandra Prakapenia, Kristian Barlinn, et al.
Pageof 23